Skip to content

Comparison of breads containing flaxseed and sesame on the blood pressure of patients with mild to moderate hypertension

Comparison of breads containing flaxseed and sesame on the blood pressure of patients with stage I hypertension

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2016050327729N1
Enrollment
84
Registered
2016-05-23
Start date
2016-05-21
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension. Essential (primary) hypertension

Interventions

Intervention 1: Patients in group A will receive 30 grams of powdered flaxseed by using 90 gram bread daily. Intervention 2: Patients in group B will receive 30 grams of powdered sesame by using 90 g
Treatment - Other
Patients in group A will receive 30 grams of powdered flaxseed by using 90 gram bread daily
Patients in group B will receive 30 grams of powdered sesame by using 90 gram bread daily

Sponsors

Vice chancellor for Research and Technology of Shahid Sadoughi University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: age between 30 to 65 years; stage I hypertension (Systolic Blood Pressure (SBP) 140-159 mmHg, Diastolic Blood Pressure (DBP) 90-99 mmHg) using prevailed treatment; using a particular anti-hypertensive therapy for at least 3 months and Exclusion Criteria: pregnant women or women planning to get pregnant; being allergic to sesame or flaxseed; suffering from intestinal diseases such as Crohn's disease, colitis, peptic ulcer, irritable bowel syndrome (IBS), and other severe systemic diseases like systemic lupus erythematosus (SLE), cancer, or stage IV respiratory diseases; history of myocardial infarction; coronary bypass surgery during last 6 months; stage II hypertension; diabetic patients; routinely using nonsteroidal anti-inflammatory drugs (NSAID's); change of antihypertensive drugs during the study

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Systolic blood pressure. Timepoint: prior to study, Seventh week, and at the end of study. Method of measurement: in mmHg using mercuric manometer.;Diastolic blood pressure. Timepoint: prior to study, Seventh week, and at the end of study. Method of measurement: in mmHg using mercuric manometer.

Secondary

MeasureTime frame
Body Mass Index (BMI). Timepoint: prior to study, Seventh week, and at the end of study. Method of measurement: kg/m^2 ; it is calculated measuring weight in kilogram and height in meter.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMoneyreh Modares Mosadegh

Shahid Sadoughi University of Medical Sciences

modares@ssu.ac.ir; mo_modares@yahoo.com; moneyrehmodares@gmail.com+98 35 3820 3418

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026